A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Resmed Inc stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 9,154 shares of RMD stock, worth $2.15 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
9,154
Previous 7,852 16.58%
Holding current value
$2.15 Million
Previous $1.5 Million 48.7%
% of portfolio
0.01%
Previous 0.01%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$186.94 - $252.92 $243,395 - $329,301
1,302 Added 16.58%
9,154 $2.24 Million
Q2 2024

Jul 26, 2024

BUY
$173.83 - $220.63 $151,405 - $192,168
871 Added 12.48%
7,852 $1.5 Million
Q1 2024

Apr 24, 2024

SELL
$165.79 - $198.03 $1.31 Million - $1.57 Million
-7,903 Reduced 53.1%
6,981 $1.38 Million
Q4 2023

Feb 09, 2024

BUY
$134.65 - $174.81 $1.27 Million - $1.65 Million
9,442 Added 173.5%
14,884 $2.56 Million
Q3 2023

Oct 24, 2023

BUY
$136.29 - $225.35 $253,908 - $419,827
1,863 Added 52.05%
5,442 $805,000
Q2 2023

Jul 13, 2023

BUY
$209.98 - $240.96 $78,532 - $90,119
374 Added 11.67%
3,579 $782,000
Q1 2023

May 11, 2023

BUY
$205.07 - $236.53 $22,762 - $26,254
111 Added 3.59%
3,205 $702,000
Q4 2022

Feb 08, 2023

SELL
$205.77 - $233.97 $19,548 - $22,227
-95 Reduced 2.98%
3,094 $644,000
Q3 2022

Oct 17, 2022

SELL
$212.32 - $243.58 $49,258 - $56,510
-232 Reduced 6.78%
3,189 $0
Q2 2022

Jul 13, 2022

BUY
$191.41 - $252.08 $71,013 - $93,521
371 Added 12.16%
3,421 $0
Q1 2022

May 12, 2022

BUY
$216.12 - $261.47 $89,473 - $108,248
414 Added 15.71%
3,050 $0
Q4 2021

Feb 03, 2022

BUY
$248.03 - $268.66 $40,180 - $43,522
162 Added 6.55%
2,636 $0
Q3 2021

Nov 02, 2021

BUY
$247.68 - $297.36 $172,137 - $206,665
695 Added 39.07%
2,474 $0
Q2 2021

Aug 10, 2021

SELL
$187.97 - $247.09 $15,977 - $21,002
-85 Reduced 4.56%
1,779 $0
Q1 2021

May 07, 2021

SELL
$179.46 - $222.28 $47,915 - $59,348
-267 Reduced 12.53%
1,864 $0
Q4 2020

Feb 04, 2021

SELL
$167.5 - $220.59 $54,270 - $71,471
-324 Reduced 13.2%
2,131 $0
Q3 2020

Oct 29, 2020

SELL
$168.14 - $205.63 $231,696 - $283,358
-1,378 Reduced 35.95%
2,455 $0
Q2 2020

Jul 27, 2020

BUY
$142.29 - $192.0 $33,011 - $44,544
232 Added 6.44%
3,833 $0
Q1 2020

May 08, 2020

BUY
$114.34 - $176.62 $101,876 - $157,368
891 Added 32.88%
3,601 $0
Q4 2019

Feb 04, 2020

SELL
$126.52 - $156.7 $5,566 - $6,894
-44 Reduced 1.6%
2,710 $0
Q3 2019

Nov 06, 2019

BUY
$123.37 - $140.33 $21,219 - $24,136
172 Added 6.66%
2,754 $0
Q3 2019

Oct 28, 2019

BUY
$123.37 - $140.33 $1,850 - $2,104
15 Added 0.58%
2,582 $0
Q2 2019

Aug 15, 2019

SELL
$97.37 - $123.27 $1.17 Million - $1.48 Million
-12,025 Reduced 82.41%
2,567 $0
Q1 2019

May 08, 2019

SELL
$91.56 - $117.84 $11,719 - $15,083
-128 Reduced 0.87%
14,592 $0
Q4 2018

Feb 05, 2019

BUY
$98.06 - $115.33 $111,984 - $131,706
1,142 Added 8.41%
14,720 $0
Q3 2018

Nov 02, 2018

BUY
$103.52 - $115.55 $96,273 - $107,461
930 Added 7.35%
13,578 $0
Q2 2018

Aug 10, 2018

BUY
$93.62 - $107.93 $1.18 Million - $1.37 Million
12,648 New
12,648 $0

Others Institutions Holding RMD

About RESMED INC


  • Ticker RMD
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 146,459,008
  • Market Cap $34.4B
More about RMD
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.